Search companies or stocks...
ONCBeOne Medicines Ltd.
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010…
Current stock price of BeOne Medicines Ltd. (ONC) stock is $358.65. The stock price is -0.26% lower in the session. The intraday range can be seen from this page. Volume of BeOne Medicines Ltd. (ONC) stock is 348.54K.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of BeOne Medicines Ltd. (ONC) can change with earnings, company news, and overall market sentiment. BeOne Medicines Ltd. operates in the Healthcare / Medical - Pharmaceuticals market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether BeOne Medicines Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ONC on this page is 63.14. EPS on this page is 5.68. Compare those figures with peers and growth expectations before deciding if the current BeOne Medicines Ltd. price is justified.
Historical performance for BeOne Medicines Ltd. (ONC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ONC reacted to past earnings and market events.
Buying BeOne Medicines Ltd. (ONC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
